In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90.4, a high estimate of $103.00, and a low estimate of $80.00. This current ...

Truist lowered the firm’s price target on Globus Medical (GMED) to $80 from $82 and keeps a Hold rating on the shares as part of a broad ...